Table 1:
Residue | Compounda | Peptidea | Thurlkillb | Nozakic | Castanẽdad |
---|---|---|---|---|---|
Asp | 3.7±0.07 | 3.8±0.05 | 3.67±0.04 | 4.0 | 3.90±0.01 |
Glu | 4.2±0.11 | 4.1±0.05 | 4.25±0.05 | 4.4 | 4.36±0.01 |
His | 6.4±0.03 | 6.4±0.03 | 6.54±0.04 | 6.3 | n/d |
HID | 7.0±0.04 | 7.0±0.05 | n/d | 6.92e | n/d |
HIE | 6.5±0.05 | 6.5 0.02 | n/d | 6.53e | n/d |
Error bars of the calculated pKa’s are the standard deviations based on five independent sets of REX titration runs, each lasting 1 ns per replica. Blocked model compound refers to Ac- X-NH2, while pentapeptide refers to Ac-Ala-Ala-X-Ala-Ala-NH2, where X is the titratable residue Asp, Glu or His.
pKa’s of pentapeptides in 0.1 M salt solution determined by Thurlkill et al. using NMR.44 These pKa’s were used as the model pKa’s in our simulations.
pKa’s of blocked amino acids given by Nozaki and Tanford46 using potentiometric titration. Ionic strength is unclear.
pKa’s of tripeptides Ac-Ala-X-Ala-NH2 in 0.1 M salt solution determined by Castañeda et al. using NMR.39
HID refers to the titration HID ⇌ HIP. HIE refers to the titration HIP ⇌ HIE.
pKa’s of model compounds measured by Tanokura using NMR titration.47